Cargando…
Ethics of Infection Control Measures for Carriers of Antimicrobial Drug–Resistant Organisms
Many countries have implemented infection control measures directed at carriers of multidrug-resistant organisms. To explore the ethical implications of these measures, we analyzed 227 consultations about multidrug resistance and compared them with the literature on communicable disease in general....
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106419/ https://www.ncbi.nlm.nih.gov/pubmed/30124192 http://dx.doi.org/10.3201/eid2409.171644 |
_version_ | 1783349775120203776 |
---|---|
author | Rump, Babette Timen, Aura Hulscher, Marlies Verweij, Marcel |
author_facet | Rump, Babette Timen, Aura Hulscher, Marlies Verweij, Marcel |
author_sort | Rump, Babette |
collection | PubMed |
description | Many countries have implemented infection control measures directed at carriers of multidrug-resistant organisms. To explore the ethical implications of these measures, we analyzed 227 consultations about multidrug resistance and compared them with the literature on communicable disease in general. We found that control measures aimed at carriers have a range of negative implications. Although moral dilemmas seem similar to those encountered while implementing control measures for other infectious diseases, 4 distinct features stand out for carriage of multidrug-resistant organisms: carriage presents itself as a state of being; carriage has limited relevance for the health of the carrier; carriage has little relevance outside healthcare settings; and antimicrobial resistance is a slowly evolving threat on which individual carriers have limited effect. These features are of ethical relevance because they influence the way we traditionally think about infectious disease control and urge us to pay more attention to the personal experience of the individual carrier. |
format | Online Article Text |
id | pubmed-6106419 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-61064192018-09-01 Ethics of Infection Control Measures for Carriers of Antimicrobial Drug–Resistant Organisms Rump, Babette Timen, Aura Hulscher, Marlies Verweij, Marcel Emerg Infect Dis Perspective Many countries have implemented infection control measures directed at carriers of multidrug-resistant organisms. To explore the ethical implications of these measures, we analyzed 227 consultations about multidrug resistance and compared them with the literature on communicable disease in general. We found that control measures aimed at carriers have a range of negative implications. Although moral dilemmas seem similar to those encountered while implementing control measures for other infectious diseases, 4 distinct features stand out for carriage of multidrug-resistant organisms: carriage presents itself as a state of being; carriage has limited relevance for the health of the carrier; carriage has little relevance outside healthcare settings; and antimicrobial resistance is a slowly evolving threat on which individual carriers have limited effect. These features are of ethical relevance because they influence the way we traditionally think about infectious disease control and urge us to pay more attention to the personal experience of the individual carrier. Centers for Disease Control and Prevention 2018-09 /pmc/articles/PMC6106419/ /pubmed/30124192 http://dx.doi.org/10.3201/eid2409.171644 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Perspective Rump, Babette Timen, Aura Hulscher, Marlies Verweij, Marcel Ethics of Infection Control Measures for Carriers of Antimicrobial Drug–Resistant Organisms |
title | Ethics of Infection Control Measures for Carriers of Antimicrobial Drug–Resistant Organisms |
title_full | Ethics of Infection Control Measures for Carriers of Antimicrobial Drug–Resistant Organisms |
title_fullStr | Ethics of Infection Control Measures for Carriers of Antimicrobial Drug–Resistant Organisms |
title_full_unstemmed | Ethics of Infection Control Measures for Carriers of Antimicrobial Drug–Resistant Organisms |
title_short | Ethics of Infection Control Measures for Carriers of Antimicrobial Drug–Resistant Organisms |
title_sort | ethics of infection control measures for carriers of antimicrobial drug–resistant organisms |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106419/ https://www.ncbi.nlm.nih.gov/pubmed/30124192 http://dx.doi.org/10.3201/eid2409.171644 |
work_keys_str_mv | AT rumpbabette ethicsofinfectioncontrolmeasuresforcarriersofantimicrobialdrugresistantorganisms AT timenaura ethicsofinfectioncontrolmeasuresforcarriersofantimicrobialdrugresistantorganisms AT hulschermarlies ethicsofinfectioncontrolmeasuresforcarriersofantimicrobialdrugresistantorganisms AT verweijmarcel ethicsofinfectioncontrolmeasuresforcarriersofantimicrobialdrugresistantorganisms |